Biodefense is a measure to combat the potential effects of bioterrorism that utilizes biological agents, or deploys biological weaponry. Bioterrorism is a deliberate release of biological agents such as bacteria, virus, germs or toxins which may be in natural or human modified form, in order to make them more virulent, or to enhance their potential to cause infection, or to make them drug resistant. These biological agents can be transmittedthrough water, air, food or from person to person.Biodefense is usually utilized in two ways, either as a defense against an attack on a military target or civil population. Defense against an attack on acivilian is largely based on the detection and methods by which casualties and loss of water or food can be minimized. Biodefense against an attack on military targets is concerned with preparing military personnelready to respond to bioterrorism.
The global biodefense market is witnessing an admirable growth due to the disease surveillance mission which has become increasingly important with the fear of bioterrorism. After the attack of September 11, 2001 came the subsequent outbreak of anthrax, spores of which were mailed through the U.S. postal system. These events brought into notice that all levels of government need to focus on improving public health preparedness and to improve the response time for the next disaster. Bioterrorism preparedness funding has enabled the Public Health Services to significantly enhance the reach of its surveillance activities, thus more effectively monitor the community’s health. After the incidence, the focus was shifted to the development of tests and procedures to detect and identify bio threat agents. Recent outbreak in the form of Ebola and nuclear crisis in Japan are expected to significantly drive the growth of the biodefense market.
Get Free PDF Brochure for more Professional and Technical industry insights: http://bit.ly/2d5pwSM
In terms of geography, North America followed by Europe accounted for the largest share of biodefense market due to enhanced lab capabilities, and improved activity for implementing rapid health alert system. Asia Pacific is expected to be a prospective biodefense market due to the rising adoption rate of precise analytical instruments and highly developing biotechnology industry. Moreover, other regions such as the Middle East and Latin America are expected to be the potential market in the near future due to expansion of major biotechnology players in these regions.
A new report by Transparency Market Research briefs readers about the global biodefense market and also lists key players operating in the market. Biodefense combats possible effects of bioterrorism that deploys biological weaponry or uses biological agents. Biodefense is used as a protection against attack on civil population or on a military target. The biological agents are transmitted through food, water, and air. Biodefense is used to prepare the military personnel to fight bioterrorism.
The report, titled “Biodefense Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 – 2023,” briefs readers about various types of biological agents. Category A biological agents have a high death rate, are contagious, and carry a high impact on people. Category A biological agents can be anthrax, smallpox, ebola, botulism, bubonic plague, and tularemia. Category B biological agents are comparatively easy to spread and carry low mortality rate. Category C biological agents are easily available, easily produced, and carry high mortality rate.
The report highlights a few techniques used for the identification and commercial detection of biological threat agents. Some of the techniques listed in the report are manual biological tests, immunological detection devices, automated biochemical tests, bioluminescence detection, and bucleic acid detection via quantitative PCR. Key companies are working on developing new technologies in the market to capture a larger share in the years to come. Some of the developing technologies listed in the report are biochemical detection, immunological detection, tissue and cell-based detection, chemical and physical detection, and nucleic acid detection.
View exclusive Global strategic Business report : http://www.transparencymarketresearch.com/biodefense-market.html
Alnylam Pharmaceuticals, Dynavax Technologies, Inc, Emergent BioSolutions, SIGA Technologies, PharmAthene, Inc., Acambis plc, Evogen, Inc., and Human Genome Sciences are some of the key companies listed in the report by analysts. Key players are expecting a tough competition from the new entrants. However, with mergers and acquisitions, leading organizations are expected to maintain their dominance throughout the forecast period.
By region, the global biodefense market is divided into North America, Asia Pacific, Europe, and Rest of the World. As per the findings of the report, at present, the global biodefense market is dominated by North America. Europe is currently the second largest market in the global biodefense market. North America is expected to maintain its dominance owing to improved lab capacities. Over the past few years, there have been improvements in the implementation of rapid health alert systems. This is also predicted to propel the North America biodefense market in the near future. The expansion of biotechnology companies is likely to benefit the Middle East and Latin America markets.